BioSig Technologies, Inc. to Receive 15 Units of PURE EP™ System from Manufacturer for Commercial Installation
15 juil. 2019 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, July 15, 2019 (GLOBE NEWSWIRE) -- New units to be prepped for next phase of targeted commercial launch strategy Company includes 3 additional hospitals to its list of medical...
Manasi Patwardhan Joins BioSig as Director of Strategic Planning
11 juil. 2019 07h52 HE
|
BioSig Technologies, Inc.
Westport, CT, July 11, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed...
BioSig Technologies, Inc. Added to Membership of Russell 3000® Index
01 juil. 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, July 01, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Samuel E. Navarro Appointed to BioSig Board of Directors
25 juin 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, June 25, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform...
BioSig Technologies Issues June 2019 Shareholder Letter
20 juin 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, June 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Technologies Set to Join Russell 3000® Index
10 juin 2019 09h17 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, June 10, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Allowed a U.S. Patent for PURE EP™ Simulator
06 juin 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, June 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019
03 juin 2019 13h26 HE
|
SetPoint Medical
VALENCIA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that results...
BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises
03 juin 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, June 03, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Present at the 9th Annual LD Micro Invitational
30 mai 2019 07h52 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, May 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...